HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide

  • Elena Fuchs
  • Published 2015 in Bone Marrow Transplantation

Abstract

In the past, partially HLA-mismatched related donor, or HLA-haploidentical, blood or marrow transplantation (haploBMT), for hematologic malignancies has been complicated by unacceptably high incidences of graft rejection or GvHD resulting from intense bi-directional alloreactivity. Administration of high doses of cyclophosphamide early after haploBMT… (More)
DOI: 10.1038/bmt.2015.92

Topics

5 Figures and Tables

Cite this paper

@article{Fuchs2015HLAhaploidenticalBO, title={HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide}, author={Elena Fuchs}, journal={Bone Marrow Transplantation}, year={2015}, volume={50}, pages={S31-S36} }